Advances in laser and device-based therapies have transformed the way dermatologists approach scar treatment and prevention. Listen as Jill S. Waibel, MD, FAAD and Sanna Ronkainen, MD, FAAD discuss how early intervention can help alter the course of scar formation.
This episode has been supported by an educational grant from Johnson and Johnson. The American Academy of Dermatology retains control over the episode content and interview participant selection.
Patient access and clinical efficiency remain persistent challenges in dermatology. Hear from Romana Behshad, MD, FAAD and Paras Vakharia, MD, PharmD, FAAD as they recap standout projects from the 2026 AAD Patient Safety and Quality Symposium, including strategies for reducing unnecessary skin checks, streamlining patient portal communications, and cutting documentation time with Epic's Express Lane tool.
Ichthyosis can affect nearly every aspect of daily life, with symptoms and management needs varying widely from patient to patient. Join Sanna Ronkainen, MD, FAAD, Denise Gass, and Cheryl Marie Bayart, MD, FAAD, as they discuss how individualized care can better support people living with ichthyosis.
Cutaneous vasculitis can be alarming for both patients and clinicians, particularly when the possibility of systemic disease remains uncertain. On this episode, Robert Micheletti, MD, FAAD and M. Laurin Council, MD, FAAD discuss how a focused clinical approach can help distinguish skin-limited disease from more serious systemic involvement.
Surgery remains a cornerstone of skin cancer treatment, but it is not always the only option available to patients. Hear from Josee J. Smith, MD, FAAD and Abigail Waldman, MD, FAAD as they explore how nonsurgical therapies are changing the management of select skin cancers.
Stevens-Johnson syndrome and toxic epidermal necrolysis remain rare but life-threatening dermatologic emergencies with no universally accepted treatment protocol. Listen as Sabrina Shearer, MD, FAAD, Marius Anton Ionescu, MD, PhD, IFAAD, and Jose Dario Martinez Villarreal, MD, IFAAD discuss how clinicians can navigate persistent uncertainty in the care of these critically ill patients.
Arthropod-related skin conditions can be difficult to diagnose, particularly when the offending insect or mite is not immediately apparent. Join Sanna Ronkainen, MD, FAAD and Eric Winfield Hossler, MD, FAAD as they explore how careful observation and clinical investigation can help uncover what is truly bugging a patient.
Cutaneous T-cell lymphoma can be difficult to recognize, particularly when it resembles more common inflammatory skin conditions. Hear from Auris Huen, PharmD, MD, FAAD and Alyx Cali Rosen Aigen, MD, FAAD as they discuss how recognizing subtle clinical clues can help dermatologists identify CTCL earlier and improve the path to diagnosis.
Patient demand for nonsurgical skin tightening continues to grow as new technologies expand treatment possibilities. In this episode, Hillary Johnson-Jahangir, MD, PhD, FAAD and Catherine DiGiorgio, MD, FAAD discuss the latest advances in nonsurgical skin tightening and tissue remodeling.
Molluscum contagiosum can persist for years, causing frustration for patients, families, and clinicians alike. Hear from Mia Hornberger, MD and Adelaide Hebert, MD, FAAD as they discuss evolving treatment strategies and the impact of newly FDA-approved therapies for molluscum contagiosum.
As treatment options for hair loss continue to expand, dermatologists play an increasingly important role in guiding patients through the hair restoration process. Join Hillary Johnson-Jahangir, MD, PhD, FAAD and Marc Avram, MD, FAAD as they discuss contemporary strategies for hair transplantation and long-term maintenance.
The skin is often the first window into systemic autoimmune disease, placing dermatologists at the forefront of diagnosis and management. Hear from Dawn M.R. Davis, MD, FAAD and Joseph Merola, MD, MSc, FAAD as they discuss practical approaches to caring for patients with lupus and other rheumatologic diseases.
Long regarded as a cosmetic condition, vitiligo is increasingly recognized as a chronic autoimmune disease with significant psychosocial consequences. Hear from M. Laurin Council, MD, FAAD, Nada Elbuluk, MD, FAAD, and Jackie Gardner as they discuss the evolving landscape of vitiligo care.